CTRI/2009/091/000291已完成2 期
A Phase IIa Randomized, Double-Blind, Parallel-Group, Placebo and Active-Controlled, Clinical Trial to Study the Efficacy and Safety of MK0974 Co-Administered With Ibuprofen or Acetaminophen in Patients With Migraine With or Without Aura - MK-974-046
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- Merck Co Inc
- 入组人数
- 628
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Must be 18 years of age or older
- •History of migraine with or without aura for more than 1 year with 1-8 moderate or severe migraine attacks per month in the 2 months prior to starting in the study
- •Willing to stay awake for at least 2 hours after taking study drug
- •Able to read, understand and complete questionnaires and diaries
排除标准
- •Breast-feeding, pregnant, or plan to become pregnant during the study
- •Not able to tell migraine attack from other headaches
- •Older than 50 years of age at migraine onset
- •Have more than 15 headache days per month or have taken medication for acute headache on more than 10 days per month in any of the 3 months before starting in the study
- •History of gastric or small intestinal surgery
- •History of heart attack, stroke, unstable angina, coronary artery bypass surgery or transient ischemic attack in the 3 months before starting in the study
- •Currently participating or have participated in a study with in investigational compound or device in the last 30 days
研究者
相似试验
进行中（未招募）
不适用
A Phase IIa Randomized, Double-Blind, Parallel-Group, Placebo and Active-Controlled, Clinical Trial to Study the Efficacy and Safety of MK-0974 Co-administered with Ibuprofen or Acetaminophen in Patients with Migraine With or Without Aura - Combination DosingMigraineEUCTR2008-004095-43-DEMerck & Co., Inc.628
进行中（未招募）
不适用
A Phase IIa Randomized, Double-Blind, Parallel-Group, Placebo and Active-Controlled, Clinical Trial to Study the Efficacy and Safety of MK-0974 Co-administered with Ibuprofen or Acetaminophen in Patients with Migraine With or Without Aura - Combination DosingMedDRA version: 9.1Level: LLTClassification code 10027599Term: MigraineMigraineEUCTR2008-004095-43-FIMSD Finland Oy628
进行中（未招募）
1 期
A Phase IIa Randomized, Double-Blind, Parallel-Group, Placebo and Active-Controlled, Clinical Trial to Study the Efficacy and Safety of MK-0974 Co-administered with Ibuprofen or Acetaminophen in Patients with Migraine With or Without AuraMigraineEUCTR2008-004095-43-FRaboratoires Merck Sharp & Dohme-Chibret640
进行中（未招募）
不适用
A Phase IIa Randomized, Double-Blind, Parallel-Group, Placebo and Active-Controlled, Clinical Trial to Study the Efficacy and Safety of MK-0974 Co-administered with Ibuprofen or Acetaminophen in Patients with Migraine With or Without Aura - Combination DosingMigraineEUCTR2008-004095-43-HUMerck & Co., Inc.628
进行中（未招募）
不适用
A Phase IIa Randomized, Double-Blind, Parallel-Groups, Placebo-Controlled ClinicalTrial to Study the Efficacy and Safety of MK-0724 Intravenous Infusion on theAmelioration of Neurological Damage and Recovery from Middle Cerebral ArteryIschemic StrokeEUCTR2008-002079-28-ATMerck Sharp & Dohme GmbH150